Does PEGCETACOPLAN Cause Vitreous floaters? 78 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Vitreous floaters have been filed in association with PEGCETACOPLAN (Empaveli). This represents 5.7% of all adverse event reports for PEGCETACOPLAN.
78
Reports of Vitreous floaters with PEGCETACOPLAN
5.7%
of all PEGCETACOPLAN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Vitreous floaters From PEGCETACOPLAN?
Of the 78 reports, 4 (5.1%) required hospitalization, and 2 (2.6%) were considered life-threatening.
Is Vitreous floaters Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGCETACOPLAN. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does PEGCETACOPLAN Cause?
Fatigue (135)
Visual impairment (125)
Haemoglobin decreased (106)
Haemolysis (100)
Off label use (97)
Breakthrough haemolysis (67)
Headache (66)
Product dose omission issue (59)
Uveitis (59)
Covid-19 (56)
What Other Drugs Cause Vitreous floaters?
AFLIBERCEPT (690)
BROLUCIZUMAB-DBLL (479)
RANIBIZUMAB (458)
BEVACIZUMAB (323)
ADALIMUMAB (300)
DUPILUMAB (300)
CIPROFLOXACIN (189)
FINGOLIMOD (129)
FARICIMAB\FARICIMAB-SVOA (123)
UPADACITINIB (112)
Which PEGCETACOPLAN Alternatives Have Lower Vitreous floaters Risk?
PEGCETACOPLAN vs PEGFILGRASTIM
PEGCETACOPLAN vs PEGFILGRASTIM-APGF
PEGCETACOPLAN vs PEGFILGRASTIM-BMEZ
PEGCETACOPLAN vs PEGFILGRASTIM-CBQV
PEGCETACOPLAN vs PEGFILGRASTIM-JMDB